Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Arcolab Completes Buy Of Australia’s Ascent

This article was originally published in PharmAsia News

Executive Summary

Strides Arcolab of India says it has completed its purchase of a majority stake in Ascent Pharmahealth of Australia. The purchase of a 50.1 percent interest in the firm would make Strides the fourth largest maker of generic pharmaceuticals in Australia when the deal is certified in September. The Indian firm already had an agreement with Genepharm to transfer its Australia and Asia businesses to Ascent. Shareholders have cleared a name change of Genepharm Australasia to Ascent Pharmahealth. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts